The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template
- PMID: 1371070
- DOI: 10.1021/bi00120a013
The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template
Abstract
The inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate (AZTTP) against HIV-1 reverse transcriptase (HIV-1 RT) has been further evaluated. The results indicate that the previously reported low Ki values for AZTTP against HIV-1 RT (2.35 nM) are due neither to the to the direct tight binding of AZTTP to HIV-1 RT nor to the interaction of the enzyme with AZTMP moiety terminated primer-templates, but instead they are an artifact of the use of a homotemplate-primer [poly(rA).oligo(dT)]. With a set of RNAs of defined sequence as templates, we demonstrate that the observed Ki value for AZTTP depends on the length of the poly(rA) region following the primer in the RNA template. The more adenosyl residues in the RNA template that are available for processive incorporation of TMP moieties, the lower is the observed Ki value for AZTTP. Since the potencies of new inhibitors of HIV-1 RT are usually compared with that for AZTTP, these results have important consequences for the process of discovery of new HIV inhibitors that are of potential use in AIDS therapy.
Similar articles
-
Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.J Biol Chem. 1990 Nov 25;265(33):20302-7. J Biol Chem. 1990. PMID: 1700787
-
Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.J Biol Chem. 1995 Apr 28;270(17):9740-7. doi: 10.1074/jbc.270.17.9740. J Biol Chem. 1995. PMID: 7537269
-
Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.Nucleic Acids Symp Ser. 1991;(25):27-8. Nucleic Acids Symp Ser. 1991. PMID: 1726810
-
Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.J Enzyme Inhib. 1992;6(1):35-46. doi: 10.3109/14756369209041354. J Enzyme Inhib. 1992. PMID: 1285301 Review.
-
Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo.FEBS Lett. 1991 Oct 7;291(1):1-5. doi: 10.1016/0014-5793(91)81089-q. FEBS Lett. 1991. PMID: 1718777 Review.
Cited by
-
Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor.Nucleic Acids Res. 1994 Apr 25;22(8):1437-43. doi: 10.1093/nar/22.8.1437. Nucleic Acids Res. 1994. PMID: 7514786 Free PMC article.
-
Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.Proc Natl Acad Sci U S A. 1994 May 24;91(11):4882-6. doi: 10.1073/pnas.91.11.4882. Proc Natl Acad Sci U S A. 1994. PMID: 7515182 Free PMC article.
-
Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.J Virol. 1999 Aug;73(8):6700-7. doi: 10.1128/JVI.73.8.6700-6707.1999. J Virol. 1999. PMID: 10400767 Free PMC article.
-
A cell-based strategy to assess intrinsic inhibition efficiencies of HIV-1 reverse transcriptase inhibitors.Antimicrob Agents Chemother. 2015 Feb;59(2):838-48. doi: 10.1128/AAC.04163-14. Epub 2014 Nov 17. Antimicrob Agents Chemother. 2015. PMID: 25403670 Free PMC article.
-
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6135-9. doi: 10.1073/pnas.90.13.6135. Proc Natl Acad Sci U S A. 1993. PMID: 7687061 Free PMC article.